← back to search

Paul D. Miller

University of Colorado Denver · US
Area of research
Orthopedics and Sports Medicine · Oncology
Research interest
Research interests include Medicine, Osteoporosis, Internal medicine, Denosumab, Bisphosphonate, and Bone remodeling.
h-index
citations
2,640
works
9
NIH funding
primary concept
email

Recent publications

Burosumab for the Treatment of Tumor-Induced Osteomalacia
Journal of Bone and Mineral Research 2020cited by 176position: middledoi
American Association of Clinical Endocrinologists and American College of Endocrinology Clinical Practice Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis — 2016--Executive Summary
Endocrine Practice 2016cited by 1,144position: middledoi
Further reductions in nonvertebral fracture rate with long-term denosumab treatment in the FREEDOM open-label extension and influence of hip bone mineral density after 3 years
Osteoporosis International 2015cited by 78position: middledoi
Taxonomy of rare genetic metabolic bone disorders
Osteoporosis International 2015cited by 44position: middledoi
Renal safety in patients treated with bisphosphonates for osteoporosis: A review
Journal of Bone and Mineral Research 2013cited by 117position: firstdoi
Bisphosphonate Therapy for Osteoporosis: Benefits, Risks, and Drug Holiday
The American Journal of Medicine 2012cited by 453position: middledoi
Benefits and Risks of Bisphosphonate Therapy for Osteoporosis
The Journal of Clinical Endocrinology & Metabolism 2012cited by 285position: middledoi
A Randomized, Placebo-Controlled Study of the Effects of Denosumab for the Treatment of Men with Low Bone Mineral Density
The Journal of Clinical Endocrinology & Metabolism 2012cited by 230position: middledoi
Postmenopausal osteoporosis treatment with antiresorptives: Effects of discontinuation or long-term continuation on bone turnover and fracture risk—a perspective
Journal of Bone and Mineral Research 2012cited by 113position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

E. Michael Lewiecki · San Francisco VA Medical Center5 papers (2012–2016)Steven Boonen · KU Leuven3 papers (2012–2013)David L. Kendler · University of British Columbia3 papers (2012–2015)Serge Ferrari · Hôpital Beau-Séjour3 papers (2012–2015)Roland Chapurlat · Université Claude Bernard Lyon 12 papers (2012–2015)Steven T. Harris · University of California, San Francisco2 papers (2012–2016)Rachel B. Wagman · Amgen (United States)2 papers (2012–2015)John P. Bilezikian · Columbia College2 papers (2012–2015)Michael R. McClung · Bone Health and Osteoporosis Foundation2 papers (2012–2012)Jean‐Yves Reginster · Royal Osteoporosis Society2 papers (2012–2015)K. Shawn Davison · University of Saskatchewan1 papers (2012–2012)Bo Abrahamsen · University of Southern Denmark1 papers (2012–2012) · 1 papers (2016–2016)Thomas J. Weber · Duke Medical Center1 papers (2020–2020) · 1 papers (2020–2020) · 1 papers (2015–2015)Rachel Pessah‐Pollack · NYU Langone Health1 papers (2016–2016) · 1 papers (2015–2015)David W. Dempster · Columbia University1 papers (2012–2012)David A. Hanley · University of Calgary1 papers (2012–2012)